Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
7
×
life sciences
national blog main
7
×
drugs
boston blog main
boston top stories
brexit
europe
europe blog main
falsified medicines
fda
innovation
labeling
mhra
national
regulations
uk
allergan
boston
detroit blog main
detroit top stories
eli lilly
genentech
national top stories
san francisco blog main
san francisco top stories
10x genomics
abbvie
amgen
anemia
antibiotic
astrazeneca
autism
autism spectrum disorder
avapritinib
avexis
bempedoic acid
biogen
blueprint medicines
What
regulatory
7
×
medicines
brexit
charting
choppy
course
dynamic
end
fda
period
plans
post
regulation
reveals
transition
uk
drug
wins
allergan
approval
approved
august
bio
biotech
blessing
blueprint
bosley
busy
cancer
candidate
ceo
check
cholesterol
clinical
combo
crispr
currently
cusp
days
decisions
Language
unset
Current search:
" national blog main "
×
" clinical trials "
×
regulatory
×
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
Esperion’s Combo Pill for Lowering Cholesterol Levels Wins FDA Nod
@xconomy.com
4 years ago
UK Reveals Plans For ‘Dynamic’ Post-Brexit Regulatory System
@xconomy.com
4 years ago
UK Reveals Plans For ‘Dynamic’ Post-Brexit Regulatory System
@xconomy.com
4 years ago
UK Reveals Plans For ‘Dynamic’ Post-Brexit Regulatory System
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Editas CEO Katrine Bosley to Depart on Cusp of CRISPR Clinical Trial